92
Views
19
CrossRef citations to date
0
Altmetric
Original Research

Preparation of a dual cored hepatoma-specific star glycopolymer nanogel via arm-first ATRP approach

, , , , , , & show all
Pages 3653-3664 | Published online: 11 May 2017

References

  • YinQShenJZhangZYuHLiYReversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumorAdv Drug Deliv Rev20136513–141699171523611952
  • ElsabahyMWooleyKLDesign of polymeric nanoparticles for biomedical delivery applicationsChem Soc Rev20124172545256122334259
  • DehainiDFangRHZhangLBiomimetic strategies for targeted nanoparticle deliveryBioeng Translation Med2016113046
  • LuoHCLiNYanLLigand-based targeted therapy: a novel strategy for hepatocellular carcinomaInt J Nanomedicine2017121085109628223800
  • ZhangYNPoonWTavaresaAJMcGilvrayIDChanWCNanoparticle–liver interactions: cellular uptake and hepatobiliary eliminationJ Control Release201624033234826774224
  • DingJXiaoCLiYEfficacious hepatoma-targeted nanomedicine self-assembled from galactopeptide and doxorubicin driven by two-stage physical interactionsJ Control Release2013169319320323247039
  • Alvarez-BerríosMPVivero-EscotoJLIn vitro evaluation of folic acid-conjugated redox-responsive mesoporous silica nanoparticles for the delivery of cisplatinInt J Nanomedicine2016116251626527920531
  • LiYLiuRYangJEnhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behaviorBiomaterials20154111425522960
  • WangYLiuXLiuGNovel galactosylated biodegradable nanoparticles for hepatocyte-delivery of oridoninInt J Pharm20165021–2476026911417
  • ThaoLQLeeCKimBDoxorubicin and paclitaxel co-bound lactosylated albumin nanoparticles having targetability to hepatocellular carcinomaColloids Surf B Biointerfaces201715218319128110040
  • MohamedNKHamadMAHafezMZWooleyKLElsabahyMNanomedicine in management of hepatocellular carcinoma: challenges and opportunitiesInt J Cancer201714071475148427861850
  • LiNLuoHCYangCCationic star-shaped polymer as an siRNA carrier for reducing MMP-9 expression in skin fibroblast cells and promoting wound healing in diabetic ratsInt J Nanomedicine201493377338725075185
  • SyrettJAHaddletonDMWhittakerMRDavisTPBoyerCFunctional, star polymeric molecular carriers, built from biodegradable microgel/nanogel coresChem Commun (Camb)20114751449145121180748
  • WangDJinYZhuXYanDSynthesis and applications of stimuli-responsive hyperbranched polymersProg Polym Sci201764114153
  • OhJKSiegwartDJLeeHIBiodegradable nanogels prepared by atom transfer radical polymerization as potential drug delivery carriers: synthesis, biodegradation, in vitro release, and bioconjugationJ Am Chem Soc2007129185939594517439215
  • MouQMaYZhuXYanDA small molecule nanodrug consisting of amphiphilic targeting ligand-chemotherapy drug conjugate for targeted cancer therapyJ Control Release2016230344427040815
  • ZhaoJBabiuchKLuHDagAGottschaldtMStenzelMHFructose-coated nanoparticles: a promising drug nanocarrier for triple-negative breast cancer therapyChem Commun (Camb)201450100159281593125382088
  • SongEHManganielloMJChowYHIn vivo targeting of alveolar macrophages via RAFT-based glycopolymersBiomaterials201233286889689722770567
  • KempeKXiangSDWilsonPEngineered hydrogen-bonded glycopolymer capsules and their interactions with antigen presenting cellsACS Appl Mater Interfaces2017976444645228186730
  • ZhangYChanJWMorettiAUhrichKEDesigning polymers with sugar-based advantages for bioactive delivery applicationsJ Control Release201521935536826423239
  • AhmedMNarainRThe effect of molecular weight, compositions and lectin type on the properties of hyperbranched glycopolymers as non-viral gene delivery systemsBiomaterials201233153990400122386601
  • LiuPSunYWangQSunYLiHDuanYIntracellular trafficking and cellular uptake mechanism of mPEG-PLGA-PLL and mPEG-PLGA-PLL-Gal nanoparticles for targeted delivery to hepatomasBiomaterials201435276077024148242
  • WangHXXiongMHWangYCZhuJWangJN-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liverJ Control Release2013166210611423266452
  • ChenWZouYMengFGlyco-nanoparticles with sheddable saccharide shells: a unique and potent platform for hepatoma-targeting delivery of anticancer drugsBiomacromolecules201415390090724460130
  • LuCXingMMZhongWShell cross-linked and hepatocyte-targeting nanoparticles containing doxorubicin via acid cleavable linkageNanomedicine201171808720650334
  • WangJYangGGuoXTangZZhongZZhouSRedox-responsive polyanhydride micelles for cancer therapyBiomaterials20143593080309024388799
  • ThapaBKumarPZengHNarainRAsialoglycoprotein Receptor-Mediated Gene Delivery to Hepatocytes Using Galactosylated PolymersBiomacromolecules20151693008302026258607
  • NarainRArmesSPSynthesis and aqueous solution properties of novel sugar methacrylate-based homopolymers and block copolymersBiomacromolecules2003461746175814606905
  • CummingsCMurataHKoepselRRussellAJDramatically increased pH and temperature stability of chymotrypsin using dual block polymer-based protein engineeringBiomacromolecules201415376377124506329
  • ShihYJChangYDerataniAQuemenerD“Schizophrenic” hemocompatible copolymers via switchable thermoresponsive transition of nonionic/zwitterionic block self-assembly in human bloodBiomacromolecules20121392849285822838402
  • LuoYLiuZZhangXEffect of a controlled-release drug delivery system made of oleanolic acid formulated into multivesicular liposomes on hepatocellular carcinoma in vitro and in vivoInt J Nanomedicine2016113111312927471381
  • SerraLDoménechJPeppasNADrug transport mechanisms and release kinetics from molecularly designed poly(acrylic acid-g-ethylene glycol) hydrogelsBiomaterials200627315440545116828864